DYSPNEA
Clinical trials for DYSPNEA explained in plain language.
Never miss a new study
Get alerted when new DYSPNEA trials appear
Sign up with your email to follow new studies for DYSPNEA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising COVID-19 treatment trial pulled before it began
Disease control TerminatedThis study was designed to test whether an inhaled drug called ZYESAMI could help people with severe COVID-19 avoid getting worse and needing a ventilator. It was a Phase 3 trial, meaning it was in the final stage of testing. However, the study was withdrawn before any participan…
Matched conditions: DYSPNEA
Phase: PHASE3 • Sponsor: APR Applied Pharma Research s.a. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New study aims to simplify diagnosis of hidden heart failure in breathless patients
Diagnosis OngoingThis study looks at better ways to diagnose a type of heart failure called HFpEF in people who have unexplained shortness of breath. Researchers will compare non-invasive tests to the standard invasive method in 30 adults aged 18-90. The goal is to make diagnosis easier and more …
Matched conditions: DYSPNEA
Sponsor: University of Leipzig • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Can a common steroid help cancer patients breathe easier?
Symptom relief OngoingThis study tested whether the steroid dexamethasone can reduce shortness of breath (dyspnea) in people with cancer. About 135 cancer patients with moderate to severe breathing difficulty took part. Researchers measured changes in their breathlessness over one to two weeks to see …
Matched conditions: DYSPNEA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC